AI-powered R&D Marketplace Scientist.com Streamlines Access to Drug Discovery and Sequencing Technologies

by Roman Kasianov       News

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

  
Topics: Marketing & E-commerce   
Share:   Share in LinkedIn  Share in Reddit  Share in X  Share in Hacker News  Share in Facebook  Send by email   |  

Scientist.com has announced a partnership with Evotec SE, aimed at integrating Evotec’s advanced drug discovery and development services into Scientist.com’s online research platform. This collaboration will make Evotec’s comprehensive suite of proprietary technologies accessible to registered users of Scientist.com, enhancing the platform’s ability to support pharmaceutical research across various therapeutic areas.

Scientist.com is a specialized R&D marketplace that streamlines outsourcing for the life sciences industry, particularly for pharmaceutical and biotech companies. By connecting researchers with over 4,000 pre-vetted service providers, the platform simplifies the procurement process for complex research services such as chemical synthesis, biological testing, and preclinical studies.

Business Model:

Scientist.com operates on a transaction-based model, earning fees from each research project facilitated through the platform. Additionally, suppliers can pay for premium placement and advanced tools, generating further revenue. This approach allows researchers to efficiently source highly specialized services without the need for time-consuming contract negotiations or supplier vetting.

Capabilities:

The platform supports end-to-end project management, enabling researchers to design, compare, and execute experiments seamlessly. It also integrates compliance tools for regulatory standards (GLP, GMP, ISO) and ensures secure handling of sensitive data in a HIPAA-compliant environment. Features like AI-driven supplier matching and automated contract generation further enhance the user experience, reducing procurement cycles from weeks to hours.

Impact:

Scientist.com accelerates the R&D process by offering immediate access to cutting-edge technologies like high-throughput screening and in vivo models. This enables quicker iteration and experimentation, shortening the timeline for drug discovery and development. By reducing overhead costs and ensuring regulatory compliance, the platform empowers life sciences researchers to focus more on innovation and less on administrative burdens.

In short, Scientist.com is advancing the life sciences by creating an efficient, secure, and compliant marketplace for R&D services, helping researchers bring new therapies to market faster.


Dr. Matthias Evers, Chief Business Officer of Evotec:

"At Evotec, our mission is to deliver high-quality, efficient, and innovative drug discovery services that advance the work of researchers developing novel treatments. By partnering with Scientist.com, we can expand our reach and empower more scientists in their efforts to bring new therapies to market."

Through this partnership, Scientist.com aims to simplify the procurement process for complex research projects, allowing users to seamlessly design, order, and execute experiments across a broad spectrum of therapeutic areas, including neuroscience, metabolic diseases, oncology, and infectious diseases.

Kevin Lustig, PhD, Founder and CEO of Scientist.com:

"Evotec's unwavering commitment to quality and innovation and the breadth of its offerings aligns perfectly with our mission to connect scientists with the tools and expertise they need to more rapidly advance their drug research. Through Scientist.com, virtually any research experiment in any therapeutic area can now be seamlessly designed, ordered, and executed."

Image credit: yacobchuk, iStock

Topics: Marketing & E-commerce   

Share:   Share in LinkedIn  Share in Reddit  Share in X  Share in Hacker News  Share in Facebook  Send by email